Investegate |Amolyt Pharma Announcements | Amolyt Pharma: Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group

Investegate announcements from Amolyt Pharma, Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States ,France ,American ,Toby Sykes ,Ashley Robinson ,Amolyt Pharma ,Jordyn Temperato ,Bpifrance Investissement ,Thierry Abribat ,Pamerican Society For Bone ,Linkedin ,Lifesci Advisors ,Twitter ,Novo Holdings Ventures ,Capital Group ,Lifesci Communications ,Life Sciences ,Mineral Research ,Tekla Capital Investment ,Amolyt Pharma Announces ,Seriesc Financing ,Sofinnova Partners ,Intermediate Capital ,Intermediate Capital Group ,Andera Partners ,Novo Holdings ,Inovo Ventures ,Kurma Partners ,Sectoral Asset Management ,Mass General Brigham Ventures ,Agricole Creation ,Relyens Innovation Sant ,Turenne Capital ,American Society ,Sci Advisors ,Investegate Announcements ,Investegate Company Announcements ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,